Centre for Biomedical Research in the Mental Health Network (CIBERSAM)
If you are the contact person for this centre and you wish to make any changes, please contact us.
Senior scientist at the Institute for Biomedical Research of Barcelona (IIBB-CSIC), principal investigator at CIBERSAM and head of the Systems Neuropharmacology group at IDIBAPS-Fundació Clínic.
Lecturer of the Department of Social Psychology and Quantitative Psychology at the University of Barcelona, researcher at the Bellvitge Biomedical Research Institute (IDIBELL) and CIBERSAM
Professor of Psychiatry at the University of Barcelona, Head of the Psychiatry and Psychology Department at Hospital Clínic in Barcelona, and researcher at the Biomedical Research Centre in Mental Health (CIBERSAM)
Head of the psychiatry department at the Fundación Jiménez Diaz, psychiatry professor at the Universidad Autónoma de Madrid
Professor at the Department of Psychiatry of the School of Medicine of the Universidad Autónoma de Madrid and member of CIBERSAM
A study led by Spanish researchers and published in Science Advances has tested a new technique to improve gene therapy treatments for Parkinson's disease. Using ultrasound, they have managed to open the blood-brain barrier in specific areas, allowing the viruses used in the therapy to pass through and better reach the desired brain areas. After testing it on monkeys and three patients -patients were not given gene therapy, but the efficacy of the technique was tested using a radiotracer that does not normally cross the blood-brain barrier-, their conclusions are that the technique is safe and feasible and "could allow early and frequent interventions to treat neurodegenerative diseases".
The rate of death by suicide in Spain has increased between 2018 and 2021, according to a report presented today by the Complutense University of Madrid, the Centre for Biomedical Research in Mental Health Network (CIBERSAM) and the Hospital del Mar in Barcelona, which points to the influence of the pandemic in this increase. In 2021, a total of 4,003 people died from this cause, 5.5% more than in 2018. During the pandemic, mortality by suicide was greater among people living in large cities and provincial capitals. The report, which includes data from 2000 to 2021, also shows the increase in deaths by suicide that occurred during the period of the economic crisis, from 2008 to 2014.
Procrastination in a sample of more than 3,500 students was associated with the development of both mental and physical health problems nine months later, according to a study conducted at several universities in Sweden. The results are published in the journal JAMA Network Open.
Two studies published in the journal Nature Communications have found specific characteristics in the microbiota of people with depression, including populations of different ethnicities and habits.
A phase 2 clinical trial has examined the use of the hallucinogen psilocybin in different amounts for the treatment of resistant depression. The results are published in the New England Journal of Medicine.
Research among more than 7,000 US adults shows small changes in extraversion, agreeableness, openness to change and conscientiousness between the period before the covid-19 pandemic and the year 2022, especially in younger people. The study is published in PLOS ONE.
Psychological distress, including depression, anxiety, worry, perceived stress and loneliness, prior to covid-19 infection was associated with an increased risk of persistent covid, according to research published in JAMA Psychiatry.
A study published today in the journal PLoS ONE examines the effectiveness of antidepressant treatments in improving patients' quality of life over time.